Wells Fargo raises Glaukos target price to $226 from $178
GKOS•Wells Fargo raised its target price for Glaukos to $226 from $178.
Related News
Phathom Pharmaceuticals Q3 2026 net revenues climb 71% year over year to $84.7 million
PHAT•
ThyssenKrupp to publish annual group financial report
TK•
European property slump deepens as higher borrowing costs force price cuts
BX•
Leonardo DRS beats Q3 revenue and profit estimates, raises 2026 guidance
DRS•
Cheniere Energy raises 2026 consolidated adjusted EBITDA guidance to $8.75 billion-$9.25 billion
LNG•